Abstract
In May 2011, the Office of Inspector General (OIG) of the Department of Health and Human Services issued a report on the use of atypical antipsychotic medications in elderly nursing facility residents. The report found that 95% of the use of these medications was either for off-label use or in patients for whom a "black box" warning was applicable. The report described the use of these medications as "unnecessary" and "inappropriate." The Board of Directors of the American Society of Consultant Pharmacists has approved this position statement as part of an effort to provide context and clinical background that was missing from the OIG report.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
